WHO ICTRP trial
A Phase 2/3 Study of AMG531 in Patients with Aplastic Anemia
JPRN-jRCT2080224878 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080224878 |
|---|---|
| Public title | A Phase 2/3 Study of AMG531 in Patients with Aplastic Anemia |
| Scientific title | A Phase 2/3 Study of AMG531 Combined with Ciclosporin A in Patients with Aplastic Anemia Previously Untreated with Immunosuppressive Therapy |
| Primary sponsor | Kyowa Kirin Co., Ltd |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2-3 |
| Countries | Japan;Asia except Japan |
| Conditions | Aplastic Anemia |
| Interventions | investigational material(s) Generic name etc : AMG531 INN of investigational material : romiplostim Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material… |
| Registration date | Sep 18, 2019 |
| Target size | 24 |
| Secondary IDs | NCT04095936;JapicCTI-194962 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: